NYSE · Financial Statements

Hims & Hers Health, Inc. (HIMS) Revenue, Earnings & Financial Statements

$17.55 NYSE: HIMS Market Cap $3.97B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Hims & Hers Health, Inc. most recently reported annual revenue of $2.3B, net profit of $128.0M. Revenue grew at an average annual rate of 73.6% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Hims & Hers Health, Inc.: Revenue rose from $83.0M in 2019 to $2.3B in 2025, a change of +2728.9% over 6 years; net profit was positive in 2 of 7 reported years; operating margin moved from -90.1% to 4.5%, a shift of +94.6 percentage points; the most recent year shows net profit of $128.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$83.0M$149.0M$272.0M$527.0M$872.0M$1.5B$2.3B
Operating Expenses$157.0M$164.0M$387.0M$596.0M$901.0M$1.4B$2.2B
Operating Profit−$74.0M−$15.0M−$115.0M−$69.0M−$29.0M$62.0M$106.0M
Operating Margin-90.1%-10.2%-42.3%-13.0%-3.4%4.2%4.5%
Other Income$2.0M−$3.0M$4.0M$3.0M$8.0M$10.0M$18.0M
Interest$0$0$0$0$0$0$0
Depreciation$0$1.0M$4.0M$7.0M$10.0M$17.0M$55.0M
Profit Before Tax−$72.0M−$18.0M−$111.0M−$66.0M−$22.0M$72.0M$124.0M
Tax rate (%)-0.1%-0.7%2.8%0.1%-9.2%-75.8%-3.6%
Net Profit−$72.0M−$18.0M−$108.0M−$66.0M−$24.0M$126.0M$128.0M
EPS−$2.07−$0.51−$0.58−$0.32−$0.11$0.53$0.51

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$247.0M$278.0M$316.0M$402.0M$481.0M$586.0M$545.0M$599.0M$618.0M$608.0M$753.0M$890.0M
Operating Expenses$247.0M$268.0M$305.0M$379.0M$463.0M$528.0M$518.0M$587.0M$609.0M$625.0M$850.0M$957.0M
Operating Profit$0$10.0M$11.0M$22.0M$19.0M$58.0M$27.0M$12.0M$9.0M−$16.0M−$97.0M−$66.0M
Operating Margin-0.2%3.6%3.5%5.6%3.9%9.9%4.9%2.0%1.5%-2.7%-12.9%-7.4%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$2.0M$12.0M$13.0M$24.0M$22.0M$60.0M$33.0M$12.0M$18.0M−$102.0M−$93.0M−$46.0M
Tax rate (%)43.3%10.3%0.9%-220.4%-16.8%18.2%-29.4%-29.1%-12.3%9.3%6.8%28.6%
Net Profit$1.0M$11.0M$13.0M$76.0M$26.0M$49.0M$43.0M$16.0M$21.0M−$92.0M−$86.0M−$33.0M
EPS$0.01$0.05$0.06$0.32$0.11$0.20$0.17$0.06$0.08−$0.40−$0.37−$0.14

Over the 7 years reported for Hims & Hers Health, Inc., borrowings increased from $2.0M in 2019 to $1.1B in 2025, cash stood at $229.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.90 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$72.0M$119.0M$421.0M$366.0M$441.0M$708.0M$2.2B
Current Assets$70.0M$113.0M$270.0M$217.0M$265.0M$396.0M$768.0M
Cash$23.0M$27.0M$72.0M$47.0M$97.0M$221.0M$229.0M
Inventory$4.0M$4.0M$14.0M$22.0M$22.0M$64.0M$116.0M
Receivables$1.0M$1.0M$4.0M$3.0M$7.0M$6.0M$32.0M
Fixed Assets$0$0$5.0M$16.0M$46.0M$93.0M$449.0M
Capital Work in Progress$0$0$0$0$0$0$0
Investments$38.0M$277.0M$175.0M$133.0M$124.0M$80.0M$700.0M
Other Assets$0$0$111.0M$111.0M$111.0M$113.0M$278.0M
Total Liabilities$207.0M$266.0M$86.0M$55.0M$97.0M$231.0M$1.6B
Current Liabilities$21.0M$15.0M$79.0M$48.0M$88.0M$221.0M$404.0M
Borrowings$2.0M$0$5.0M$5.0M$10.0M$11.0M$1.1B
Other Liabilities$206.0M$266.0M$80.0M$49.0M$87.0M$219.0M$493.0M
Equity$5.0M$0$0$0$0$0$0
Reserves−$135.0M−$147.0M$335.0M$312.0M$344.0M$477.0M$541.0M

For Hims & Hers Health, Inc., operating cash flow was positive in 3 of 7 reported years; free cash flow in the latest year was $74.0M; free cash flow was positive in 3 of 7 years; financing activities used $207.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow−$75.0M−$2.0M−$34.0M−$27.0M$73.0M$251.0M$300.0M
Investing Cash Flow−$41.0M−$44.0M−$161.0M$27.0M−$39.0M−$72.0M−$1.3B
Financing Cash Flow$0−$3.0M−$39.0M−$33.0M−$11.0M−$108.0M−$207.0M
Net Cash Flow−$19.0M$6.0M$44.0M−$25.0M$50.0M$124.0M$8.0M
Free Cash Flow−$77.0M−$7.0M−$39.0M−$34.0M$47.0M$198.0M$74.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.57
EV / EBITDA-49.29
FCF Yield0.65%
Quick Ratio0.84
Interest Coverage—
Return 1Y-45.27%
Return 3Y168.07%
Return 5Y181.22%

Hims & Hers Health, Inc. (HIMS) financials — frequently asked questions

What is Hims & Hers Health, Inc.'s annual revenue?

Hims & Hers Health, Inc. (HIMS) reported annual revenue of $2.3B in its most recent fiscal year.

What is Hims & Hers Health, Inc.'s net profit?

Hims & Hers Health, Inc. (HIMS) reported net profit of $128.0M in its most recent fiscal year.

What is HIMS EV/EBITDA?

Hims & Hers Health, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -49.29. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Care Facilities stocks

HCA revenue $75.6BTHC revenue $21.3BEHC revenue $5.9BDVA revenue $13.6BENSG revenue $5.1BUHS revenue $17.4BCHE revenue $2.5BLFST revenue $1.4BOPCH revenue $5.7BACHC revenue $3.3BAll Medical - Care Facilities stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
HIMS Overview HIMS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.